SYRE
USDSpyre Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$21.880
Máximo
$22.540
Mínimo
$21.150
Volumen
0.80M
Fundamentos de la Empresa
Capitalización de Mercado
1.7B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.83M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Reported positive interim Phase 1 results for SPY003, a next-generation anti-IL-23 antibody, demonstrating the molecule was well-tolerated and exhibited an ~85-day half-life supporting quarterly or twice annual
Spyre Therapeutics to Participate in Upcoming November Investor Conferences
WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of
Acciones Relacionadas
PCG
Pacific Gas & Electric Co.
NEWTI
NewtekOne Inc. 8.00% Fixed Rate Senior Notes due 2028
PCAR
PACCAR Inc.
TLIS
Talis Biomedical Corporation
PXDT
Pixie Dust Technologies Inc. American Depositary Shares
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.